WASHINGTON, Aug. 5 -- Food and Drug Administration has issued a notice called: Establishment of a Quantitative Medicine Innovation Network: Scope, Feasibility, and Opportunities; Request for Information.
The notice was published in the Federal Register on Aug. 5 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Center for Drug Evaluation and Research (CDER) within the Food and Drug Administration (FDA or Agency), through its Quantitative Medicine Center of Excellence (QM CoE), is announcing a request for information to inform the development of a Quantitative Medicine Innovation Network (QMIN). The vision for the QMIN is to create a cross-sector collaborative platform that accelerates...